Management of Graves’ Hyperthyroidism: More Than a Century of Progression

AuthorHengameh Abdien
AuthorAtieh Amouzegaren
Issued Date2020-06-30en
AbstractContext: There are three therapeutic modalities for the management of Graves’ disease (GD), including thyroid surgery, radioactive iodine (RAI), and antithyroid drugs (ATDs). We aimed to briefly review the history of these treatment strategies and their advantages and disadvantages. Evidence Acquisition: We searched PubMed for English language articles using pertinent search terms. Results: Each treatment modality for GD is accompanied by several advantages and disadvantages. Nowadays, ATDs are the most commonly prescribed therapy for GD worldwide. The lack of well-designed, large RCTs comparing three different treatments for hyperthyroidism concerning various short-term and long-term outcomes has led to remarkable uncertainty in the preference of each of these treatments, as is evident in relevant guidelines from different societies. Recently, the efficacy and safety of long-term use of ATDs have been documented. Conclusions: Pros and cons of each therapeutic modality for Graves’ hyperthyroidism should be taken into account during the physician-patient discussion to select the primary treatment. Considering recent data about the long-term efficacy and safety of ATDs, it seems that the appropriate selection of Graves’ patients for long-term ATD therapy can be a new avenue in the treatment and even cure of GD.en
DOIhttps://doi.org/10.5812/ijem.103943en
KeywordHyperthyroidismen
KeywordSurgeryen
KeywordGraves’ Diseaseen
KeywordRadioiodineen
KeywordAntithyroid Drugen
PublisherBrieflandsen
TitleManagement of Graves’ Hyperthyroidism: More Than a Century of Progressionen
TypeReview Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ijem-18-Suppl-103943.pdf
Size:
114.7 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF